AmSurg Earnings Preview

Investors hope AmSurg (Nasdaq: AMSG  ) will top analyst estimates once again after beating predictions by $0.02 in the previous quarter. The company will unveil its latest earnings on Thursday, Feb. 23. AmSurg develops, acquires, and operates ambulatory surgery centers, or ASCs, in partnership with physicians.

What analysts say:

  • Buy, sell, or hold?: Analysts think investors should stand pat on AmSurg with seven of 10 analysts rating it hold. Analysts like AmSurg better than competitor LCA-Vision overall. Zero out of one analysts rate LCA-Vision a buy compared to one of 10 for AmSurg.
  • Revenue forecasts: On average, analysts predict $213.7 million in revenue this quarter. That would represent a rise of 15.7% from the year-ago quarter.
  • Wall Street earnings expectations: The average analyst estimate is earnings of $0.46 per share. Estimates range from $0.41 to $0.47.

What our community says:
CAPS All-Stars are solidly behind the stock, with 95% granting it an "outperform" rating. The community at large is in line with the All-Stars, with 94.7% assigning it a rating of "outperform." Despite the majority sentiment in favor of AmSurg, the stock has a middling CAPS rating of three out of five stars.

AmSurg's income has fallen year-over-year by an average of 7.5% over the past five quarters. Revenue has now gone up for three straight quarters.

Now, a look at how efficient management has been at running the business. Margins illustrate how efficiently a company captures portions of sales dollars. AmSurg has seen decreasing net margin year-over-year for the last four quarters. Net margin reflects what percentage of each dollar earned by the company becomes profit. Here are AmSurg's reported margins for the last four quarters:






Gross Margin





Operating Margin





Net Margin





For all our AmSurg-specific analysis, including earnings and beyond, add AmSurg to My Watchlist.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Earnings estimates provided by Zacks.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1783990, ~/Articles/ArticleHandler.aspx, 10/22/2016 12:08:20 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 14 hours ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:00 PM
AMSG $65.49 Down -1.51 -2.25%
AmSurg CAPS Rating: *****